Junghang Luo (Junhang Luo, Jun-Hang Luo)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 24

Top Venues

Cancer medicine

Oncogene

Nature communications

Clinical and translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Da-Ming Xu, Xiao-Yu Zhuang, Hua-Li Ma, Zai-Shang Li, Li-Chao Wei, Junghang Luo, Hui Han
Altered tumor microenvironment heterogeneity of penile cancer during progression from non-lymphatic to lymphatic metastasis. Cancer medicine 13 (14) (2024)
Kang-Bo Huang, Cheng-Peng Gui, Yun-Ze Xu, Xue-Song Li, Hong-Wei Zhao, Jia-Zheng Cao, Yu-Hang Chen, Yi-Hui Pan, Bing Liao, Yun Cao, Xin-Ke Zhang, Hui Han, Fang-Jian Zhou, Ran-Yi Liu, Wen-Fang Chen, Ze-Ying Jiang, Zi-Hao Feng, Fu-Neng Jiang, Yan-Fei Yu, Sheng-Wei Xiong, Guan-Peng Han, Qi Tang, Kui Ouyang, Gui-Mei Qu, Ji-Tao Wu, Ming Cao, Bai-Jun Dong, Yi-Ran Huang, Jin Zhang, Cai-Xia Li, Pei-Xing Li, Wei Chen, Wei-De Zhong, Jian-Ping Guo, Zhi-Ping Liu, Jer-Tsong Hsieh, Dan Xie, Mu-Yan Cai, Wei Xue, Jin-Huan Wei, Junghang Luo
A multi-classifier system integrated by clinico-histology-genomic analysis for predicting recurrence of papillary renal cell carcinoma. Nature communications 15 (1) (2024)
Da-Ming Xu, Xiao-Yu Zhuang, Hua-Li Ma, Zai-Shang Li, Li-Chao Wei, Junghang Luo, Hui Han
Altered tumor microenvironment heterogeneity of penile cancer during progression from non-lymphatic to lymphatic metastasis. Cancer medicine 13 (14) (2024)
Pengju Li, Quanhui Xu, Minyu Chen, Jiangquan Zhu, Yinghan Wang, Mukhtar A Mumin, Kangbo Huang, Zeying Jiang, Hui Liang, Qiong Deng, Zhu Wang, Bing Liao, Wenfang Chen, Yun Cao, Jiazheng Cao, Junghang Luo
A nomogram based on TFE3 IHC results and clinical factors as a preliminary screening scheme for TFE3-rearranged renal cell carcinoma. Cancer medicine 13 (5) (2024)
Kang-Bo Huang, Cheng-Peng Gui, Yun-Ze Xu, Xue-Song Li, Hong-Wei Zhao, Jia-Zheng Cao, Yu-Hang Chen, Yi-Hui Pan, Bing Liao, Yun Cao, Xin-Ke Zhang, Hui Han, Fang-Jian Zhou, Ran-Yi Liu, Wen-Fang Chen, Ze-Ying Jiang, Zi-Hao Feng, Fu-Neng Jiang, Yan-Fei Yu, Sheng-Wei Xiong, Guan-Peng Han, Qi Tang, Kui Ouyang, Gui-Mei Qu, Ji-Tao Wu, Ming Cao, Bai-Jun Dong, Yi-Ran Huang, Jin Zhang, Cai-Xia Li, Pei-Xing Li, Wei Chen, Wei-De Zhong, Jian-Ping Guo, Zhi-Ping Liu, Jer-Tsong Hsieh, Dan Xie, Mu-Yan Cai, Wei Xue, Jin-Huan Wei, Junghang Luo
A multi-classifier system integrated by clinico-histology-genomic analysis for predicting recurrence of papillary renal cell carcinoma. Nature communications 15 (1) (2024)
Pengju Li, Quanhui Xu, Minyu Chen, Jiangquan Zhu, Yinghan Wang, Mukhtar A Mumin, Kangbo Huang, Zeying Jiang, Hui Liang, Qiong Deng, Zhu Wang, Bing Liao, Wenfang Chen, Yun Cao, Jiazheng Cao, Junghang Luo
A nomogram based on TFE3 IHC results and clinical factors as a preliminary screening scheme for TFE3-rearranged renal cell carcinoma. Cancer medicine 13 (5) (2024)
Kang-Bo Huang, Cheng-Peng Gui, Yun-Ze Xu, Xue-Song Li, Hong-Wei Zhao, Jia-Zheng Cao, Yu-Hang Chen, Yi-Hui Pan, Bing Liao, Yun Cao, Xin-Ke Zhang, Hui Han, Fang-Jian Zhou, Ran-Yi Liu, Wen-Fang Chen, Ze-Ying Jiang, Zi-Hao Feng, Fu-Neng Jiang, Yan-Fei Yu, Sheng-Wei Xiong, Guan-Peng Han, Qi Tang, Kui Ouyang, Gui-Mei Qu, Ji-Tao Wu, Ming Cao, Bai-Jun Dong, Yi-Ran Huang, Jin Zhang, Cai-Xia Li, Pei-Xing Li, Wei Chen, Wei-De Zhong, Jian-Ping Guo, Zhi-Ping Liu, Jer-Tsong Hsieh, Dan Xie, Mu-Yan Cai, Wei Xue, Jin-Huan Wei, Junghang Luo
A multi-classifier system integrated by clinico-histology-genomic analysis for predicting recurrence of papillary renal cell carcinoma. Nature communications 15 (1) (2024)
Da-Ming Xu, Xiao-Yu Zhuang, Hua-Li Ma, Zai-Shang Li, Li-Chao Wei, Junghang Luo, Hui Han
Altered tumor microenvironment heterogeneity of penile cancer during progression from non-lymphatic to lymphatic metastasis. Cancer medicine 13 (14) (2024)
Jun Lu, Liang-Min Fu, Yun Cao, Yong Fang, Jia-Zheng Cao, Yi-Hui Pan, Jun-Jie Cen, Yan-Ping Liang, Zhen-Hua Chen, Jin-Huan Wei, Yong Huang, Mukhtar Adan Mumin, Quan-Hui Xu, Ying-Han Wang, Jiang-Quan Zhu, Hui Liang, Zhu Wang, Qiong Deng, Wei Chen, Xiao-Han Jin, Zhi-Ping Liu, Junghang Luo
LZTFL1 inhibits kidney tumor cell growth by destabilizing AKT through ZNRF1-mediated ubiquitin proteosome pathway. Oncogene (2023)
Anze Yu, Jiao Hu, Liangmin Fu, Gaowei Huang, Dingshan Deng, Mingxiao Zhang, Yinghan Wang, Guannan Shu, Lanyu Jing, Huihuang Li, Xu Chen, Taowei Yang, Jinhuan Wei, Zhen-Hua Chen, Xiongbing Zu, Junghang Luo
Bladder cancer intrinsic LRFN2 drives anticancer immunotherapy resistance by attenuating CD8 + T cell infiltration and functional transition. Journal for immunotherapy of cancer 11 (10) (2023)
Junjie Cen, Yanping Liang, Zihao Feng, Xu Chen, Jinlong Chen, Yinghan Wang, Jiangquan Zhu, Quanhui Xu, Guannan Shu, Wenbin Zheng, Hui Liang, Zhu Wang, Qiong Deng, Jiazheng Cao, Junghang Luo, Xiaohan Jin, Yong Huang
Hsa_circ_0057105 modulates a balance of epithelial-mesenchymal transition and ferroptosis vulnerability in renal cell carcinoma. Clinical and translational medicine 13 (8) (2023)
Guannan Shu, Xuanxuan Lu, Yihui Pan, Junjie Cen, Kangbo Huang, Mi Zhou, Jun Lu, Jiaqi Dong, Hui Han, Wei Chen, Juan Lin, Junghang Luo, Jiaxing Zhang
Exosomal circSPIRE1 mediates glycosylation of E-cadherin to suppress metastasis of renal cell carcinoma. Oncogene (2023)
Jun Lu, Liang-Min Fu, Yun Cao, Yong Fang, Jia-Zheng Cao, Yi-Hui Pan, Jun-Jie Cen, Yan-Ping Liang, Zhen-Hua Chen, Jin-Huan Wei, Yong Huang, Mukhtar Adan Mumin, Quan-Hui Xu, Ying-Han Wang, Jiang-Quan Zhu, Hui Liang, Zhu Wang, Qiong Deng, Wei Chen, Xiao-Han Jin, Zhi-Ping Liu, Junghang Luo
LZTFL1 inhibits kidney tumor cell growth by destabilizing AKT through ZNRF1-mediated ubiquitin proteosome pathway. Oncogene (2023)
Cheng-Gong Luo, Cheng-Peng Gui, Gao-Wei Huang, Jin-Long Chen, Jia-Ying Li, Peng-Ju Li, Quan-Hui Xu, Ying-Han Wang, Jiang-Quan Zhu, Hui Liang, Zhu Wang, Qiong Deng, Jia-Zheng Cao, Junghang Luo, Jun Lu, Wei Chen
Identification of ZDHHC1 as a Pyroptosis Inducer and Potential Target in the Establishment of Pyroptosis-Related Signature in Localized Prostate Cancer. Oxidative medicine and cellular longevity 2022 (2022)
U-Ging Lo, Yu-An Chen, Junjie Cen, Su Deng, Junghang Luo, Haiyen Zhau, Lin Ho, Chih-Ho Lai, Ping Mu, Leland W K Chung, Jer-Tsong Hsieh
The driver role of JAK-STAT signalling in cancer stemness capabilities leading to new therapeutic strategies for therapy- and castration-resistant prostate cancer. Clinical and translational medicine 12 (8) (2022)
Cheng-Gong Luo, Cheng-Peng Gui, Gao-Wei Huang, Jin-Long Chen, Jia-Ying Li, Peng-Ju Li, Quan-Hui Xu, Ying-Han Wang, Jiang-Quan Zhu, Hui Liang, Zhu Wang, Qiong Deng, Jia-Zheng Cao, Junghang Luo, Jun Lu, Wei Chen
Identification of ZDHHC1 as a Pyroptosis Inducer and Potential Target in the Establishment of Pyroptosis-Related Signature in Localized Prostate Cancer. Oxidative medicine and cellular longevity 2022 (2022)
Xiaoling Ying, Bixia Liu, Zusen Yuan, Yapeng Huang, Cong Chen, Xu Jiang, Haiqing Zhang, Defeng Qi, Shulan Yang, Shuibin Lin, Junghang Luo, Weidong Ji
METTL1-m 7 G-EGFR/EFEMP1 axis promotes the bladder cancer development. Clinical and translational medicine 11 (12) (2022)
Yiming Tang, Fei Liu, Xiaopeng Mao, Pengju Li, Mukhtar A Mumin, Jiaying Li, Yi Hou, Hongde Song, Haishan Lin, Lei Tan, Chengpeng Gui, Mingxiao Zhang, Liangmin Fu, Wei Chen, Yong Huang, Junghang Luo
The impact of tumor size on the survival of patients with small renal masses: A population-based study. Cancer medicine 11 (12) (2022)
Yu-Lu Peng, Long-Bin Xiong, Zhao-Hui Zhou, Kang Ning, Zhen Li, Ze-Shen Wu, Min-Hua Deng, Wen-Su Wei, Ning Wang, Xiang-Peng Zou, Zhi-Song He, Ji-Wei Huang, Junghang Luo, Jian-Ye Liu, Nan Jia, Yun Cao, Hui Han, Sheng-Jie Guo, Pei Dong, Chun-Ping Yu, Fang-Jian Zhou, Zhi-Ling Zhang
Single-cell transcriptomics reveals a low CD8 + T cell infiltrating state mediated by fibroblasts in recurrent renal cell carcinoma. Journal for immunotherapy of cancer 10 (2) (2022)
Ming-Xiao Zhang, Jia-Li Wang, Cheng-Qiang Mo, Xiao-Peng Mao, Zi-Hao Feng, Jia-Ying Li, Hai-Shan Lin, Hong-de Song, Quan-Hui Xu, Ying-Han Wang, Jun Lu, Jin-Huan Wei, Hui Han, Wei Chen, Hai-Ping Mao, Junghang Luo, Zhen-Hua Chen
CircME1 promotes aerobic glycolysis and sunitinib resistance of clear cell renal cell carcinoma through cis-regulation of ME1. Oncogene 41 (33) (2022)
Xueyi Zheng, Ruixuan Wang, Xinke Zhang, Yan Sun, Haohuan Zhang, Zihan Zhao, Yuanhang Zheng, Jing Luo, Jiangyu Zhang, Hongmei Wu, Dan Huang, Wenbiao Zhu, Jianning Chen, Qinghua Cao, Hong Zeng, Rongzhen Luo, Peng Li, Lilong Lan, Jing-Ping Yun, Dan Xie, Wei-Shi Zheng, Junghang Luo, Mu-Yan Cai
A deep learning model and human-machine fusion for prediction of EBV-associated gastric cancer from histopathology. Nature communications 13 (1) (2022)
Ming-Xiao Zhang, Li-Zhen Zhang, Liang-Min Fu, Hao-Hua Yao, Lei Tan, Zi-Hao Feng, Jia-Ying Li, Jun Lu, Yi-Hui Pan, Guan-Nan Shu, Peng-Ju Li, Yi-Ming Tang, Zhuang-Yao Liao, Jin-Huan Wei, Wei Chen, Jian-Ping Guo, Junghang Luo, Zhen-Hua Chen
Positive feedback regulation of lncRNA PVT1 and HIF2α contributes to clear cell renal cell carcinoma tumorigenesis and metastasis. Oncogene 40 (37) (2021)
Kang-Hua Xiao, Kai Teng, Yun-Lin Ye, Lei Tan, Ming-Kun Chen, Hai-Tao Liang, Zi-Hao Feng, Jin-Ling Duan, Min-Hua Deng, Wen-Su Wei, Junghang Luo, Zi-Ke Qin, Dan Xie
Kinesin family member C1 accelerates bladder cancer cell proliferation and induces epithelial-mesenchymal transition via Akt/GSK3β signaling. Cancer science 110 (9) (2019)
Zi-Hao Feng, Yong Fang, Liang-Yun Zhao, Jun Lu, Yong-Qian Wang, Zhen-Hua Chen, Yong Huang, Jin-Huan Wei, Yan-Ping Liang, Jun-Jie Cen, Yi-Hui Pan, Bing Liao, Wei Chen, Junghang Luo
RIN1 promotes renal cell carcinoma malignancy by activating EGFR signaling through Rab25. Cancer science 108 (8) (2017)

Junghang Luo.css-eqlu8i{font-size:small;padding-left:4px;} (Junhang Luo, Jun-Hang Luo)

Publication Activity (10 Years)

Top Topics

Top Venues

Junghang Luo (Junhang Luo, Jun-Hang Luo)